Melanoma Matters

Summary One wonders if Prof Martin Gore ever dreamed he would be mentioned in the same context as HRH and Taylor Swift. If he's listening, he must know which of the goldilocks chairs he occupies. In...

14 Okt 202431min

Summary In this episode of Melanoma Matters, Sapna Patel and James Larkin discuss the IMMUNED study, a randomized phase 2 trial for resected stage 4 melanoma with no evidence of disease (NED). They ex...

14 Okt 202435min

Summary In this conversation, James Larkin and Sapna Patel discuss the S1801 study, a neoadjuvant study in melanoma. They talk about the background and design of the study, including the decision to c...

14 Okt 202429min

Summary In this conversation, James Larkin and Sapna Patel discuss the PRADO study, which focuses on neoadjuvant therapy for melanoma. The study explores the use of personalized response-driven approa...

14 Okt 202426min

Summary In this conversation, James Larkin and Sapna Patel discuss neoadjuvant treatment in melanoma. They start by talking about the best films they've seen in the last five years, then move on to th...

14 Okt 202419min

Summary Birth order and bad second languages and Bolivia. In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin discuss the Checkmate 915 trial, a significant study in the adjuvant t...

14 Okt 202420min

Summary In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin have a disastrous quickfire discussing their would-be porn star names and eventually move on to the Checkmate 76K study,...

14 Okt 202416min

Summary In this episode of Melanoma Matters, James Larkin and Sapna Patel discuss the Keynote 716 trial, focusing on the treatment of stage 2 melanoma. They explore the implications of adjuvant therap...

14 Okt 202431min